Marc Oczachowski – CEO, EDAP TMS, France
Marc Oczachowski, CEO of EDAP TMS, a French medtech and global leader in therapeutic ultrasound, elaborates on the history of the company while discussing their newest innovation for the noninvasive…
Address: 143/147 Bd Anatole France, Saint Denis 93285,France
Tel: +33 (0)1 55 87 30 00
The French Agency for the Safety of Health Products (AFSSAPS) was created by the Act of 1 July 1998 establishing a watchdog and security and safety. This is a public institution under the State supervision of the Ministry of Health. Afssaps’s mission is to ensure job security, quality and proper use of these health products.
Its jurisdiction applies to medicines and raw materials, medical devices and medical devices in vitro diagnostic (or laboratory reagents), for therapeutic products and biological products of human origin (labile blood products, organs, tissues, cells, products of gene and cell therapies), cosmetics and tattoo products.
AFSSAPS is an integeral piece of the public health system. Its activity assessment, monitoring and inspection is based on a high-level expertise to make available health products as safe as possible. It extends into the development and dissemination of information tailored to the needs of health professionals and the public. Moreover, AFSSAPS ensures that each patient receives treated products including pharmaceutical quality, the safety profile and efficacy are demonstrated and validated.
* Public Institution of the State created March 9, 1999, under supervision of the Minister for Health
* A team of nearly a thousand professionals
* More than 2,000 experts meeting in committees and working groups
* Laboratories in Saint-Denis, Lyon and Montpellier
* An operating budget of 109.6 million € for 2009
Pharmacopée
Actualité
Qu’est-ce que la Pharmacopée ?
La Pharmacopée française – 11e édition
Monographies en enquête publique
Réglementation
Marc Oczachowski, CEO of EDAP TMS, a French medtech and global leader in therapeutic ultrasound, elaborates on the history of the company while discussing their newest innovation for the noninvasive…
In an exclusive interview, Dominique Le Guludec, president of the French National Authority for Health (Haute Autorité de Santé (HAS)), offers her insider comments on the changes in French healthcare…
David Lescuyer, managing director of Skyepharma, a specialized CDMO, reflects on the past three years of the company as it transitioned from a drug delivery platform to a fully-fledged service…
Dr Marc-Alexander Burmeister, president of B. Braun in France, shares the exciting changes to come for B. Braun globally and in France, and discusses the shifting environment of healthcare in…
Françoise Alliot-Launois, VP of the French League Against Rheumatism (AFLAR), discusses the issues around bone and joint infections in France, AFLAR’s work to help patients suffering from these diseases, and…
Finn Søndergaard, CEO of Intsel Chimos, shares the motivation behind the company’s two recent acquisitions of Diverchim and Centre Lab, and the new strategic opportunities to expand as a full-service…
Abbvie France’s Pierre-Claude Fumoleau outlines his strategic priorities for the affiliate, AbbVie’s unique corporate culture and ethos, and how he envisions upcoming regulatory reforms playing out in France. We…
Denis Delval, CEO of iconic French pharma firm LFB since December 2017, discusses his key priorities to build the new LFB. My vision is that we should be strong…
Biotest’s Olivier Samama outlines the changes that the takeover of the company has had on the French affiliate, the country’s plasma market and pricing policy. The product offering remains…
Edouard Bieth, managing director of Tillotts Pharma in France, discusses the opportunities and challenges of opening an affiliate in the country and the uniqueness of Tillotts’ specialization in gastrointestinal drugs.…
The healthcare and life sciences industries, as they become more advanced and complex, increasingly require government involvement to ensure clinical compliance, ethical behaviour and the well-being of the nation. The health sector is…
Arnaud Gobet, president of Innothera, discusses how the company balances its unique and diverse offering of medical devices, hygiene and protection products and pharmaceuticals, Innothera’s burgeoning international footprint and the…
See our Cookie Privacy Policy Here
